Aster Capital Management DIFC Ltd Decreases Stock Holdings in Corteva, Inc. (NYSE:CTVA)

Aster Capital Management DIFC Ltd lessened its stake in shares of Corteva, Inc. (NYSE:CTVA) by 13.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,465 shares of the company’s stock after selling 852 shares during the quarter. Aster Capital Management DIFC Ltd’s holdings in Corteva were worth $311,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the stock. Sepio Capital LP increased its stake in shares of Corteva by 3.2% in the 4th quarter. Sepio Capital LP now owns 5,361 shares of the company’s stock worth $305,000 after purchasing an additional 166 shares in the last quarter. Quadrant Capital Group LLC lifted its position in shares of Corteva by 4.9% in the fourth quarter. Quadrant Capital Group LLC now owns 7,001 shares of the company’s stock worth $399,000 after buying an additional 329 shares in the last quarter. Ilmarinen Mutual Pension Insurance Co boosted its stake in Corteva by 44.4% during the fourth quarter. Ilmarinen Mutual Pension Insurance Co now owns 65,000 shares of the company’s stock valued at $3,702,000 after buying an additional 20,000 shares during the last quarter. Envestnet Asset Management Inc. grew its holdings in Corteva by 36.9% during the 4th quarter. Envestnet Asset Management Inc. now owns 2,215,926 shares of the company’s stock valued at $126,219,000 after buying an additional 597,739 shares in the last quarter. Finally, Aviva PLC raised its holdings in shares of Corteva by 1,424.4% during the 4th quarter. Aviva PLC now owns 411,385 shares of the company’s stock worth $23,432,000 after acquiring an additional 384,398 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors.

Corteva Stock Performance

Corteva stock opened at $55.54 on Tuesday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45. The company has a market capitalization of $37.93 billion, a PE ratio of 43.05, a P/E/G ratio of 1.68 and a beta of 0.73. The company has a 50 day moving average price of $62.18 and a 200-day moving average price of $60.28. Corteva, Inc. has a fifty-two week low of $50.01 and a fifty-two week high of $66.24.

Corteva (NYSE:CTVA) last issued its earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. As a group, equities analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Monday, March 3rd were given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.22%. The ex-dividend date of this dividend was Monday, March 3rd. Corteva’s dividend payout ratio (DPR) is 52.71%.

Insider Buying and Selling at Corteva

In other news, insider Brian Titus sold 26,560 shares of the company’s stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the transaction, the insider now directly owns 11,347 shares of the company’s stock, valued at approximately $723,257.78. This represents a 70.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.14% of the company’s stock.

Analyst Upgrades and Downgrades

CTVA has been the topic of several research reports. Bank of America boosted their price target on shares of Corteva from $69.00 to $73.00 and gave the stock a “buy” rating in a research report on Tuesday, February 11th. Argus upgraded shares of Corteva from a “hold” rating to a “buy” rating and set a $69.00 target price on the stock in a research report on Monday, March 31st. KeyCorp lifted their price target on Corteva from $68.00 to $70.00 and gave the stock an “overweight” rating in a research report on Friday, February 7th. Citigroup upped their price objective on Corteva from $69.00 to $74.00 and gave the company a “buy” rating in a research report on Wednesday, January 29th. Finally, UBS Group dropped their target price on Corteva from $74.00 to $73.00 and set a “buy” rating for the company in a report on Friday, January 10th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Corteva has an average rating of “Moderate Buy” and a consensus target price of $68.06.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.